A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer’s disease, a new study shows.

Led by researchers at NYU Grossman School of Medicine, the investigation showed that elderly monkeys had up to 59 percent fewer plaque deposits in their brains after treatment with CpG oligodeoxynucleotides (CpG ODN), compared with untreated animals. These amyloid beta plaques are protein fragments that clump together and clog the junctions between nerve cells (neurons).

Brains of treated animals also had a drop in levels of toxic tau. This nerve fiber protein can destroy neighboring tissue when disease-related changes to its chemical structure causes it to catch on other cells.

“Our findings illustrate that this therapy is an effective way of manipulating the immune system to slow neurodegeneration,” says Akash Patel, MS, an assistant research scientist in the Center for Cognitive Neurology at NYU Langone Health.


DAILY DOSE: Measles Death Confirmed as U.S. Cases Top 3,100; Gene Editing Turns Pancreatic Cells Into Insulin Producers.
A measles outbreak has resulted in over 3,100 cases and one infant …
Study Finds Food Insecurity Remains in Historically Redlined Neighborhoods
A Texas A&M study finds crime, poor housing, and weak schools โ€” …
A Field Guide for the Wild West of AI-Assisted Science
UC Santa Barbara researchers publish ten rules for using generative AI in …
Researchers Show That Intermittent Fasting Maintains Long-Term Weight Loss, Regardless of Meal Timing
A 12-month follow-up finds 16:8 intermittent fasting sustains weight loss whether the …

A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer’s disease, a new study shows.

Led by researchers at NYU Grossman School of Medicine, the investigation showed that elderly monkeys had up to 59 percent fewer plaque deposits in their brains after treatment with CpG oligodeoxynucleotides (CpG ODN), compared with untreated animals. These amyloid beta plaques are protein fragments that clump together and clog the junctions between nerve cells (neurons).

Brains of treated animals also had a drop in levels of toxic tau. This nerve fiber protein can destroy neighboring tissue when disease-related changes to its chemical structure causes it to catch on other cells.

“Our findings illustrate that this therapy is an effective way of manipulating the immune system to slow neurodegeneration,” says Akash Patel, MS, an assistant research scientist in the Center for Cognitive Neurology at NYU Langone Health.


Processingโ€ฆ
Success! You're on the list.

Leave a Reply

Trending

Discover more from Scientific Inquirer

Subscribe now to keep reading and get access to the full archive.

Continue reading